Johnson & Johnson (JNJ)
265.88
-2.16
(-0.81%)
USD |
NYSE |
Aug 31, 16:00
266.04
+0.16
(+0.06%)
After-Hours: 20:00
Johnson & Johnson Cash from Operations (Annual) : 24.53B for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 24.53B |
| December 31, 2024 | 24.27B |
| December 31, 2023 | 22.79B |
| December 31, 2022 | 21.19B |
| December 31, 2021 | 23.41B |
| December 31, 2020 | 23.54B |
| December 31, 2019 | 23.42B |
| December 31, 2018 | 22.20B |
| December 31, 2017 | 21.06B |
| December 31, 2016 | 18.77B |
| December 31, 2015 | 19.28B |
| December 31, 2014 | 18.47B |
| December 31, 2013 | 17.41B |
| December 31, 2012 | 15.40B |
| December 31, 2011 | 14.30B |
| December 31, 2010 | 16.38B |
| December 31, 2009 | 16.57B |
| December 31, 2008 | 14.97B |
| December 31, 2007 | 15.25B |
| December 31, 2006 | 14.25B |
| December 31, 2005 | 11.88B |
| December 31, 2004 | 11.13B |
| December 31, 2003 | 10.60B |
| Date | Value |
|---|---|
| December 31, 2002 | 8.176B |
| December 31, 2001 | 8.864B |
| December 31, 2000 | 6.563B |
| December 31, 1999 | 5.677B |
| December 31, 1998 | 4.886B |
| December 31, 1997 | 4.343B |
| December 31, 1996 | 3.891B |
| December 31, 1995 | 3.382B |
| December 31, 1994 | 2.975B |
| December 31, 1993 | 2.168B |
| December 31, 1992 | 2.141B |
| December 31, 1991 | 1.675B |
| December 31, 1990 | 1.657B |
| December 31, 1989 | 1.25B |
| December 31, 1988 | 888.00M |
| December 31, 1987 | 1.094B |
| December 31, 1986 | 1.092B |
| December 31, 1985 | 1.073B |
| December 31, 1984 | 919.50M |
| December 31, 1983 | 549.90M |
| December 31, 1982 | 606.20M |
| December 31, 1981 | 639.00M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Eli Lilly & Co. | 16.81B |
| Merck & Co., Inc. | 16.47B |
| Pfizer Inc. | 11.70B |
| Bristol Myers Squibb Co. | 14.16B |
| Liquidia Corp. | -35.69M |